North American schizophrenia drugs market is projected to grow at a significant CAGR of 2.1% during the forecast period (2020-2026). The increasing incidence of anxiety disorders in North America is generating the demand for different types of medication and therapies for its treatment and thereby is expected to propel the growth of the schizophrenia drugs […]
Category Archives: Pharmaceuticals
The European schizophrenia drug market is projected to grow at a significant CAGR of around 2.5% during the forecast period (2020-2026). The availability of considerable resources for mental health and a sophisticated healthcare system are other key factors that are expected to promote the growth of the market. In the UK, Mental Health First Aid […]
Asia-Pacific schizophrenia drugs market is projected to grow at a significant CAGR of 3.6% during the forecast period (2020-2026). In Asia-Pacific, the schizophrenia has a high prevalence in South Asian countries as compared to the rest of the region. According to the Progress in Mind, there are significantly different medication patterns preferred across South Asian […]
Indian schizophrenia drugs market is projected to grow at a significant CAGR of 4.0% during the forecast period (2020-2026). The major contributors in the market are the female population suffering from mental health issues in the country. There is no gender difference in schizophrenia; however, a stress and mental health are some factors leads to […]
France urothelial carcinoma market is estimated to grow considerably, at a CAGR of around 9.6% during the forecast period. France is one of the leading economies and technologically advanced countries in Europe. France has a quality healthcare system and favorable government policies which is augmenting the growth of the market in France. The number of […]
European urothelial carcinoma market is estimated to grow significantly at a CAGR of around 9.2%, during the forecast period. The growth of the market is attributed to well-developed healthcare infrastructure, significant healthcare expenditure, and growing prevalence and incidence of urothelial carcinoma across many European economies. Sedentary lifestyle such as smoking, consumption of drugs, and alcohol […]
Canada urothelial carcinoma market is estimated to grow modestly at a CAGR of around 8.7% during the forecast period. Canada has a considerable market of urothelial carcinoma treatment due to the increasing healthcare expenditure and significant prevalence of urothelial carcinoma coupled with surging aging population base across the nation. According to Bladder Cancer Canada, bladder […]
Asia-Pacific urothelial carcinoma market is estimated to grow at a CAGR of around 9.4% during the forecast period. The rising healthcare industry, majorly in the emerging economies of the region such as India and China, is significantly propelling the growth of the market in Asia-Pacific. A growing number of smokers in Asian economies is one […]
The global farm animal health market is projected to grow at a significant CAGR during the forecast period. The is segmented on the basis of products and animal types. Based on the product, the market is segmented into vaccines, parasiticides, anti-infectives, and others. The vaccination segment is projected to hold a significant market share during […]
The global intravenous iron drug market is projected to grow at a CAGR of around 7% during the forecast period. Iron plays an important role in the transportation of oxygen throughout the body. The key factors that drive the growth of the global intravenous iron drug industry include the increased prevalence of various disorders such […]